A closely watched clinical trial has handed the ketogenic diet its most striking piece of evidence yet: after roughly four to five months, participants on a keto regimen saw their liver fat fall by an average of 67 percent — a reduction that dramatically outpaced both the Mediterranean diet and a conventional low-fat diet, according to results reported by researchers at Washington University in St. Louis and covered widely this week by ScienceDaily, Medical News Today, Healthline, Healio and the New York Post, among others.
The finding is notable not only for its size but for its context. All three diet groups lost broadly similar amounts of weight. The keto group's advantage, the researchers argue, came from something other than the scale.
What the trial actually measured
The study randomly assigned participants — adults who were overweight or obese and had signs of prediabetes along with excess fat stored in the liver — to one of three diets: ketogenic (very low carbohydrate, high fat), Mediterranean (plant-forward, with moderate whole grains and healthy fats), or low-fat. Participants were tracked for about four months, with imaging used to quantify liver fat and blood tests used to assess metabolic markers such as blood sugar regulation.
By the end of the intervention, roughly half of those in the keto arm no longer met the criteria for prediabetes. Liver fat in that group dropped by an average of 67 percent — a magnitude of change that, as Medical News Today and Healthline both emphasized, suggests benefits extending well beyond weight loss alone.
"Keto produced a substantially greater reduction in liver fat than the Mediterranean or low-fat diets, despite similar weight loss." — summary of the trial's central finding, as reported by multiple outlets
Why liver fat is the metric that matters
Fat accumulation in the liver — now clinically termed metabolic dysfunction-associated steatotic liver disease, or MASLD — has become one of the most common chronic liver conditions worldwide, closely tied to obesity, insulin resistance and type 2 diabetes. It is frequently silent, often discovered only when imaging or bloodwork is done for another reason, and it can progress to inflammation, fibrosis and, in a minority of cases, cirrhosis.
That makes the liver an unusually informative window into metabolic health. A diet that shrinks liver fat is, in effect, a diet that is improving how the body handles energy and insulin. As Healio framed it, keto appears to be the strongest of the popular diets for liver health specifically. News-Medical went further, describing the keto approach as excelling at "reversing prediabetes and fatty liver" — language that reflects how striking the numbers looked to specialists.
The weight-loss paradox
Perhaps the most consequential detail is that all three diets produced comparable weight loss. If the only mechanism were caloric restriction, the liver results should have tracked the scale. They didn't.
Researchers and outside experts point to several possible explanations: keto's effect on insulin levels and hepatic de novo lipogenesis (the liver's own fat-making pathway), reduced circulating triglycerides, and the rapid early depletion of glycogen and water that accompanies carbohydrate restriction. Inc. framed the result bluntly — three diets cut weight equally, but only one cut liver fat by two-thirds.
MSN and Yahoo's coverage angled toward the practical question readers are likely asking: who does this actually help? The answer emerging from the data is narrower than keto's online fan base might hope. The trial enrolled people with prediabetes and excess liver fat — a specific metabolic profile, not the general population.
The caveats clinicians keep raising
- Duration: Four to five months is short. Whether the liver-fat advantage persists at one or two years is unknown.
- Adherence: Very-low-carbohydrate diets are difficult to sustain; dropout and rebound are well documented in longer studies.
- LDL cholesterol: Some individuals experience sharp rises in LDL on keto, a concern for cardiovascular risk that this trial was not designed to settle.
- Generalisability: Participants received structured support and monitoring — conditions that rarely match how people diet in real life.
- Not a license to abandon plants: The Mediterranean diet still carries the strongest long-term evidence base for cardiovascular and overall health.
BolNews and The News reported the headline figure without the nuance; specialist outlets such as Healthline and Medical News Today paired the result with commentary from dietitians urging individualization. That split in framing — breakthrough versus caution — is characteristic of nutrition science, a field where single trials generate headlines far faster than they generate consensus.
What it means for patients
The practical takeaway is not that everyone should start a ketogenic diet. It is that diet quality and metabolic mechanism matter, and that liver fat is a measurable target that responds to carbohydrate restriction in a way that a low-fat plan may not replicate. For the roughly one in three adults worldwide with fatty liver disease, that is a meaningful new data point.
The trial also sharpens a long-running debate in nutrition science: the assumption that all calorie-equivalent diets are metabolically interchangeable. These results suggest they are not — at least not in the liver, and at least over four months.
What comes next is the harder science: longer follow-up, cardiovascular endpoints, and evidence on whether the liver-fat gains survive real-world adherence. Until then, the 67 percent figure stands as a provocative signal — strong enough to change how researchers think about diet and metabolic disease, but not yet strong enough to write a prescription.



